Taiwan FDA registration 3c1f0cab9eb395e6e0b08bade2683f6b
"Kabi" Amex blood component separator
TW: “卡比”愛美克斯血液成份分離機
Taiwan·Risk Class 2·FRESENIUS KABI WARRENDALE;; Fresenius Kabi AG·Registered Jan 17, 2011 – Jan 17, 2026ExpiredRegistration details
- Analysis ID
- 3c1f0cab9eb395e6e0b08bade2683f6b
- Customs Code
- DHA00602204300
Company information
- Manufacturer
- FRESENIUS KABI WARRENDALE;; Fresenius Kabi AG
- Manufacturer Country
- United States;;Germany
- Authorized Representative
- FRESENIUS KABI TAIWAN LIMITED
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Jan 17, 2011
- Expiry Date
- Jan 17, 2026
About this record
Access comprehensive regulatory information for "Kabi" Amex blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3c1f0cab9eb395e6e0b08bade2683f6b and manufactured by FRESENIUS KABI WARRENDALE;; Fresenius Kabi AG. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices